Diabetes Pen Companies
The market for diabetes pens involves several multinational pharmaceutical and medical device companies that manufacture insulin pens for diabetes management. These companies operate globally, including in the Americas.
The market for diabetes pens involves several multinational pharmaceutical and medical device companies that manufacture insulin pens for diabetes management. These companies operate globally, including in the Americas.
Novo Nordisk price reduction: In March 2023, Novo Nordisk announced a 75% price reduction for vials and pens of NovoLog and other insulin brands in the United States. This move is expected to increase the adoption of insulin pens, particularly among cost-conscious consumers.
Cequr's new insulin pen: In June 2022, Cequr launched its Insulin Pen 2.0TM, which features advanced features like automated insulin delivery, real-time glucose monitoring, and personalized dosing recommendations. This pen is expected to be a game-changer in the market for smart insulin pens.
List of Americas Diabetes Pen Key Companies in the Market
Diabetes Pen Market Highlights:
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)